Drugs · acquisition-cost intelligence
Cetirizine HCl
Cetirizine· ingredient cetirizineOther antiallergics· CETIRIZINE HYDROCHLORIDE 10 mg/1; CETIRIZINE HYDROCHLORIDE 5 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.04795
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other cetirizine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| All Day Allergy | $0.02152 | −$0.02640 |
| 24 hour allergy | $0.06400 | +$0.01610 |
| 24 hour allergy | $0.19380 | +$0.14590 |
| 12 hour allergy d | $0.58890 | +$0.54090 |
| ZERVIATE | $7.33 | +$7.29 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.